Process equipment expansion LCI Corporation is part of the Nederman Group and serves the process industries with two specialized programs (liquids and solids) including evaporation, drying, filtration, extrusion, spheronization, feeding, and pelleting. Potential sales opportunity: cross-sell Nederman Group capabilities and integrated process solutions to existing customers in chemical and pharmaceutical sectors, highlighting end-to-end equipment packages.

Pharma granulation link Recent news features the Dome Ex continuous wet granulation system for pharmaceutical manufacturing. This signals a growth area and customer interest in advanced granulation tech. Potential sales angle: engage pharmaceutical manufacturers and contract developers with integrated wet granulation solutions and compatibility with existing LCI process lines.

Strategic partnerships LCI has a collaboration with Buss-SMS-Canzler GmbH since 2018, suggesting openness to channel partnerships and OEM collaborations. Potential sales approach: leverage alliance to access additional regional customers, co-market capabilities, and offer bundled solutions across process stages.

Mid-market focus With 51-200 employees and a revenue range of 25–50 million, LCI sits in the mid-market industrial segment. Potential sales tactic: position as a scalable, modular solution provider to mid-sized chemical, pharma, and processing plants seeking modernization, efficiency gains, and capability upgrades without large enterprise price tags.

Digital and visibility LCI’s tech stack includes tools like Google AdSense, YouTube, and various collaboration and design platforms, indicating active marketing and digital engagement. Potential sales opportunity: run targeted digital campaigns, webinars, and demonstration content to showcase dome granulation, filtration, and drying technologies to process engineers and procurement teams.